Literature DB >> 29299590

Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus.

Julia Sanchez1, Saskia Ingen-Housz-Oro2,3, Olivier Chosidow2,3, Frank Antonicelli4, Philippe Bernard1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29299590      PMCID： PMC5885811          DOI： 10.1001/jamadermatol.2017.5176

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).

Authors:  M Hertl; H Jedlickova; S Karpati; B Marinovic; S Uzun; S Yayli; D Mimouni; L Borradori; C Feliciani; D Ioannides; P Joly; C Kowalewski; G Zambruno; D Zillikens; M F Jonkman
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-10-22       Impact factor: 6.166

2.  First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Authors:  Pascal Joly; Maud Maho-Vaillant; Catherine Prost-Squarcioni; Vivien Hebert; Estelle Houivet; Sébastien Calbo; Frédérique Caillot; Marie Laure Golinski; Bruno Labeille; Catherine Picard-Dahan; Carle Paul; Marie-Aleth Richard; Jean David Bouaziz; Sophie Duvert-Lehembre; Philippe Bernard; Frederic Caux; Marina Alexandre; Saskia Ingen-Housz-Oro; Pierre Vabres; Emmanuel Delaporte; Gaelle Quereux; Alain Dupuy; Sebastien Debarbieux; Martine Avenel-Audran; Michel D'Incan; Christophe Bedane; Nathalie Bénéton; Denis Jullien; Nicolas Dupin; Laurent Misery; Laurent Machet; Marie Beylot-Barry; Olivier Dereure; Bruno Sassolas; Thomas Vermeulin; Jacques Benichou; Philippe Musette
Journal:  Lancet       Date:  2017-03-22       Impact factor: 79.321

3.  Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.

Authors:  Giuseppe Cianchini; Francesca Lupi; Cinzia Masini; Rosamaria Corona; Pietro Puddu; Ornella De Pità
Journal:  J Am Acad Dermatol       Date:  2012-01-13       Impact factor: 11.527

4.  Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients.

Authors:  Luisa Lunardon; Kathleen J Tsai; Kathleen J Propert; Nicole Fett; John R Stanley; Victoria P Werth; Donald E Tsai; Aimee S Payne
Journal:  Arch Dermatol       Date:  2012-09

Review 5.  Efficacy of rituximab for pemphigus: a systematic review and meta-analysis of different regimens.

Authors:  Hsiao-Han Wang; Che-Wei Liu; Yu-Chuan Li; Yu-Chen Huang
Journal:  Acta Derm Venereol       Date:  2015-11       Impact factor: 4.437

6.  A single cycle of rituximab for the treatment of severe pemphigus.

Authors:  Pascal Joly; Hugo Mouquet; Jean-Claude Roujeau; Michel D'Incan; Danièle Gilbert; Serge Jacquot; Marie-Lise Gougeon; Christophe Bedane; Ralf Muller; Brigitte Dreno; Marie-Sylvie Doutre; Emmanuel Delaporte; Christine Pauwels; Nathalie Franck; Frédéric Caux; Catherine Picard; Emmanuelle Tancrede-Bohin; Philippe Bernard; François Tron; Michael Hertl; Philippe Musette
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245
  6 in total
  1 in total

1.  Rituximab in Pemphigus: Road Covered and Challenges Ahead.

Authors:  Keshavamurthy Vinay; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.